None listed
Conditions
Brief summary
This study aims to integrate early palliative care known as Care Plus in routine practice for patients with advanced cancers. Who is it for? Adults with a targeted advanced cancer who present to one of the study's hospital sites (St Vincent's Hospital Melbourne, Peter MacCallum Cancer Centre and Lyell McEwin Hospital), and who have reached a certain point in their illness will receive Care Plus as part of the hospital's new practice change. Study Details Six months prior to introducing Care Plus at each hospital site, patients with targeted advanced cancers who reach a key point in their illness will receive usual oncological care (Control group). This involves the treating clinician making referral to palliative care at their discretion. During the practice change period, in which Care Plus is introduced, all patients with targeted advanced cancers reaching a key point in their illness will, by default, receive usual oncological care by their treating clinician AND Care Plus as part of the hospital's new practice change. This involves a scheduled palliative care consultation and ongoing follow-up visits with specialists and nurse specialists. During these consultations, patients and their caregivers will have the opportunity to discuss pain and nausea management, and any other physiological, psychological, practical, social and spiritual needs. It is hoped this research will contribute to reduced hospitalisations for cancer patients, improved quality of life and improved efficiency for the healthcare system.
Interventions
Intervention: Usual oncology care + Care Plus. Care Plus involves standardised early palliative care introduced at key transition points in the cancer illness trajectory. The Care Plus palliative care consultation involves a discussion with patients and their caregiver about their individual needs, including assessment of physical, psychological, social and practical needs. The approximate duration of each consultation is between 30 minutes and 1 hour. The introduction of Care Plus will be developed, implemented and evaluated in three tertiary cancer treatment centres in the following order: (1) St Vincent's Hospital Melbourne, (2) Peter MacCallum Centre and (3) Lyell McEwin Hospital. This design stipulates 'control' periods when usual oncological care is observed, and the process of implementing Care Plus itself which includes phases of planning, engagement, intervention (practice change) and evaluation. This study will target five types of advanced cancers across the three participating sites. The study population consists of adults with one of the five targeted advanced cancers who present to the three participating sites at the time or within 6 weeks of reaching a cancer-specific 'transition point' (e.g. multiday admission with metastatic disease). The five cancer types and definition of their corresponding transition points will be nominated, and defined by key clinicians at each site. During the implementation of Care Plus (intervention arm), ALL patients with targeted advanced cancers reaching transition point will continue to receive usual oncological care + Care Plus. Care Plus involves palliative care consultation within 6 weeks of the transition point, with follow-up occurring at a minimum monthly for 3 months +/- an additional 3 month bolster as needed (determined by the treating palliative care specialist in consultation with patient and their caregiver). Care Plus is delivered by specialist palliative care consultants, or certified nurse practitioners/clinical nurse specialists. The care provided will be personalized based upon patient and caregiver need, including review of symptoms, psychological distress, additional community supports required, informational needs, illness understanding, discussion of prognosis, preferences for care, advance care planning, GP case conference. Care Plus is provided face-to-face upfront, with follow-up face-to-face or by telephone as needed. Caregivers are invited to participate in consultations. All Care Plus consultations will be recorded using the domains of PC-NAT for auditing, and cross-checked against a medical record audit of outpatient visits and GP case conferences.
Sponsors
Study design
Eligibility
Inclusion criteria
1. Patients with a targeted advanced cancer in receipt of usual care * Inclusion criteria: Adults with a targeted advanced cancer 2. Patients with a targeted advanced cancer in receipt of Care Plus (intervention) - In this period, the study will collect and analyse aggregate data of health service use and cost of patients with a targeted advanced cancer enrolled in the intervention period, and in receipt of usual care + Care Plus. * Inclusion criteria: (a) Adults with a targeted cancer; and (b) in attendance at participating hospital sites at a time of (or within 6 weeks following) defined cancer-specific 'transition point'. 3. Patients in receipt of Care Plus will be invited to participate in an interview to provide their perspectives and experiences of Care Plus as part of routine cancer care. * Inclusion criteria: (a) Adults in receipt of Care Plus as part of their routine cancer practice at participating hospital sites; and (b) able to provide consent/comply with study procedures.
Exclusion criteria
1. Under 18 years 2. Unwilling or unable to provide consent